Why the AusCann share price rocketed higher today

The Auscann Group Holdings Ltd (ASX:AC8) share price has rocketed 10.5% to 47 cents this morning. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Auscann Group Holdings Ltd (ASX: AC8) share price has been a big mover in early trade.

At the time of writing the medicinal cannabis company's shares are up over 10.5% to 47 cents.

What happened?

This morning AusCann announced that its strategic partner Tasmanian Alkaloids has been granted a medicinal cannabis licence and a research and development licence from the Office of Drug Control, meaning the company now has licenses in two Australian states.

Tasmanian Alkaloids is one of world's largest manufacturers of controlled substances and a producer of medicinal opiates.

Approximately 40% of the world's opiate crop is produced by the company at its modern manufacturing facility which is fully compliant with Good Manufacturing Practice standards.

AusCann's managing director Elaine Darby believes that this latest development means the partnership is now well positioned to "progress in our joint strategy to become a leading producer and supplier of high quality medicinal cannabis to Australian patients."

Should you invest?

As I have said many times before, I think AusCann is a company with significant potential. However, it is still very early days for medicinal cannabis and would be a somewhat speculative investment.

However, I do see an immediate need for the product, especially in the lucrative chronic pain treatment market.

The use of medicinal cannabis in existing pain management regimes involving opiates has been shown to improve pain management and quality of life outcomes according to studies. Importantly, the studies revealed less adverse side effects as well.

So with over 3 million Australians estimated to suffer from chronic pain, there could be significant demand for medicinal cannabis in the future if prescribing physicians can be convinced of the benefits.

In light of this, I'll certainly be keeping a close eye on AusCann and its other strategic partner Zelda Therapeutics Ltd (ASX: ZLD) over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »